Drug Delivery Expert Witnesses
Drug delivery disputes sit at the intersection of formulation science, regulatory strategy, and substantial commercial value. Litigation commonly arises in Hatch-Waxman and biosimilar patent cases, where the validity or infringement of claims covering extended-release formulations, transdermal systems, inhalers, or injectable platforms can determine market exclusivity worth billions of dollars. Licensing and co-development agreements generate their own disputes when a partner's delivery technology fails to achieve the pharmacokinetic profile, stability, or manufacturability the parties anticipated. In each setting, the contested question is how a particular delivery mechanism actually performs and what a skilled scientist would have understood about it at the relevant time.
Expert analysis lets attorneys translate formulation and pharmacokinetic data into evidence a court or tribunal can evaluate. In patent matters, a drug delivery expert can address claim construction from the perspective of a person of ordinary skill, analyze whether the prior art rendered a release mechanism obvious, and compare an accused product's composition and dissolution behavior against the asserted claims. In commercial disputes, the expert can review development records, bioequivalence studies, and FDA correspondence to determine whether a program faltered because of the technology itself, a partner's execution, or regulatory obstacles neither party controlled. That distinction frequently frames liability and drives the damages model that follows.
Persuasive drug delivery testimony depends on experts who understand both the bench science and the regulatory path a product must travel. Round Table Group can introduce pharmaceutical scientists, formulation chemists, and pharmacologists whose backgrounds span academic research, industry development, and regulatory review, including experience associated with organizations such as the FDA, Pfizer, Merck, and research universities such as MIT. The strongest candidates have often published on controlled-release and targeted delivery systems and have guided products from early formulation through approval. With more than 75,000 expert searches completed for litigators, we know how to align an expert's platform-specific experience with the claims and products at issue. Let us help you identify the right expert for your drug delivery matter by calling us at (202) 908-4500.